Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.

Connecticut's strategic venture capital arm, today announced that it invested approximately $7.8 million in 17 companies and venture funds during the second quarter of its fiscal year, ending December ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...

Pacer Advisors Inc. lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 7.9% in the fourth ...

Learn more about whether The Ensign Group, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor ...

Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

The National Association of Wholesaler-Distributors (NAW) announced Henry Schein Chairman and CEO Stanley Bergman will receive its Dirk Van Dongen Lifetime Achievement Award. The Award was named in ...